ASVRX
Price
$10.57
Change
+$0.09 (+0.86%)
Updated
Jan 30 closing price
Net Assets
5.36B
GMNCX
Price
$11.33
Change
+$0.08 (+0.71%)
Updated
Jan 30 closing price
Net Assets
13.03M
Ad is loading...

ASVRX vs GMNCX

Header iconASVRX vs GMNCX Comparison
Open Charts ASVRX vs GMNCXBanner chart's image
American Century Small Cap Value R
Price$10.57
Change+$0.09 (+0.86%)
VolumeN/A
Net Assets5.36B
Gabelli Global Mini Mites C
Price$11.33
Change+$0.08 (+0.71%)
VolumeN/A
Net Assets13.03M
ASVRX vs GMNCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
ASVRX vs. GMNCX commentary
Jan 31, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASVRX is a StrongBuy and GMNCX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
ASVRX has more cash in the bank: 5.36B vs. GMNCX (13M). GMNCX pays higher dividends than ASVRX: GMNCX (0.53) vs ASVRX (0.47). ASVRX was incepted earlier than GMNCX: ASVRX (15 years) vs GMNCX (6 years). ASVRX (44.00) and GMNCX (42.00) have comparable annual turnover. ASVRX has a lower initial minimum investment than GMNCX: ASVRX (2500) vs GMNCX (10000). ASVRX annual gain was more profitable for investors over the last year : 9.91 vs. GMNCX (8.33). ASVRX return over 5 years is better than : 44.16 vs. GMNCX (28.56).
ASVRXGMNCXASVRX / GMNCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence15 years6 years-
Gain YTD4.2411.995213%
Front LoadN/AN/A-
Min. Initial Investment25001000025%
Min. Initial Investment IRAN/AN/A-
Net Assets5.36B13M41,200%
Annual Yield % from dividends0.470.5389%
Returns for 1 year9.918.33119%
Returns for 3 years5.438.7762%
Returns for 5 years44.1628.56155%
Returns for 10 years24.89N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SGGDX28.670.87
+3.13%
First Eagle Gold A
PAEIX13.220.16
+1.23%
T. Rowe Price Overseas Stock Advisor
BRULX16.030.13
+0.82%
MFS Blended Research Value Equity R3
LPFCX5.76N/A
N/A
ALPS Global Opportunity C
AWMIX20.59N/A
N/A
CIBC Atlas Mid Cap Equity Institutional